2000～2002年华山医院门诊病人心血管药物使用分析  

Analysis of treatment medicines of outpatients with cardiovascular diseases in Huashan Hospital in 2000-2002

作　　者：刘晓[1] 蔡宜[1] 李中东[1] 钟明康[1] 

机构地区：[1]复旦大学附属华山医院药剂科,上海200040

出　　处：《药学服务与研究》2004年第1期58-60,共3页Pharmaceutical Care and Research

摘　　要：目的:分析华山医院心血管系统药品在2000～2002年期间的使用情况,为药品采购、供应计划的制定和临床应用提供量化的指标和数据。方法:按年度区分,分别对药品分类、进口和国产药、单个药品使用金额及百分比进行排序比较。结果:3年中,抗高血压药、抗心绞痛药、血脂调节药和抗心律失常药的使用金额分别位居第1、2、3和4位,百分比分别为55%～60%,19%～22%,15%～19%和4%～5%。其中,进口药的使用金额为国产药的4～6倍。在所有心血管药物中,氦氯地平、辛伐他汀和氯沙坦的年使用金额连续3年均位于前3位。结论:心血管系统药物临床应用广泛,用药金额呈逐年增长的趋势,应注意监测其用药变化趋势。Objective:To evaluate the situation of cardiovascular drugs used in outpatients of Shanghai Huashan Hospital in 2000-2002 years. Methods: All data related to use of cardiovascular drugs, such as types of drugs used, imported and domestic drugs, and the sum of expenses of each drug category. Results:In the period of 2000-2002, antihypertensive drugs, anti-angina drugs, blood cholesterol regulation drugs and antiarrhythmic drugs were listed at the 1st, 2nd. 3rd and the fourth positions in total cost of purchase, respectively. The total cost of purchase of imported cardiovascular drugs was 4-6 folds of that of domestic drugs. Among all cardiovascular drugs, the expenses of amlodipine, simvastatin and losartan were still listed at the first three positions. Conclusion: The cardiovascular drugs are extensively used in clinical practice. The total cost of purchase tend towards rising year by year and attention should be paid to monitor the rational utilization of drugs.

关 键 词：心血管系统药物 用药分析 门诊病人 华山医院 2000~2002年 抗高血压药 抗心绞痛药 血脂调节药 

分 类 号：R972[医药卫生—药品]